Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Available from: [6] Longo N, Frigeni M, Pasquali M
ADCs against TROP2 TROP2 is a glycoprotein transmembrane calcium signal transducer upregulated in more than 50% of lung adenocarcinoma and squamous cell carcinoma of the lung and participates in several oncogenic signaling pathways, but exhibits limited expression in normal human tissues, which makes it an attractive therapeutic blank in cancer treatment
Therefore, microsphere sustained-release technology is being utilized to enable GLP-1 drugs to be released slowly and continuously, or GLP-1 molecules are being modified and optimized through structural modifications to develop GLP-1 RAs with longer half-lives
Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells: Correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation
